Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feedergoogle.co.in
Get the latest updates from Google Alert - omalizumab directly as they happen.
Follow now 108 followers
Last updated 20 minutes ago
about 21 hours ago
... hit composite asthma clinical remission at week 24 vs 40.5% with...
1 day ago
... omalizumab. Guy Brusselle, MD, PhD, from Ghent University Hospital, breaks down...
about 20 hours ago
... 64% of dupilumab-treated patients met composite asthma clinical remission criteria at...
about 19 hours ago
Guy Brusselle, MD, PhD, of Ghent University Hospital, discusses new data from...
about 18 hours ago
试验标题:A Global, Multi-center, Open-label Study, Investigating a Remibrutinib- and Omalizumab-Based Treatment Algorithm...
1 day ago
Mor har brukt omalizumab (Xolair) 300 mg injeksjon hver 3. uke gjennom...
1 day ago
Biosimilar Omlyclo finns nu tillgänglig. Använd det mest kostnadseffektiva läkemedlet med omalizumab.
1 day ago
Originalpreparatet för omalizumab (Xolair) används vid allergisk astma, kronisk rinosinuit med näspolyper...
1 day ago
[팜뉴스=우정민 기자] 만성 두드러기 환자에서 오말리주맙(Omalizumab/ 상품명 졸레어 Xolair) 약물 치료가 3년...
1 day ago
This study aimed to evaluate the clinical efficacy of omalizumab treatment and...
1 day ago
Methods The study included 32 children and 67 adults with CSU receiving...
2 days ago
Importance Omalizumab is a recommended second-line therapy for chronic urticaria (CU), yet...